Alan L Ho, Alexander T Pearson, Siqing Fu, Marshall R Posner, Douglas Adkins, Lisle Nabell, Jiaxin Niu, Debra L Richardson, Rom S Leidner, Ki Chung, Douglas Laux, Jorge Nieva, Stuart Wong, Katerin Rojas, Ari J Rosenberg, Minh Phan, Trisha Kaufmann, Christopher Plescia, Xiaoping Qing, Corinne Iacobucci, Ilian Tchakov, Kia Katchar, Klaus Orlinger, Katia Schlienger, David G Pfister
{"title":"679 .在一项1期研究中,接受HB-200单药治疗作为二线或后期治疗的复发/转移hpv16阳性头颈癌患者肿瘤特异性CD8+ T细胞反应的特征","authors":"Alan L Ho, Alexander T Pearson, Siqing Fu, Marshall R Posner, Douglas Adkins, Lisle Nabell, Jiaxin Niu, Debra L Richardson, Rom S Leidner, Ki Chung, Douglas Laux, Jorge Nieva, Stuart Wong, Katerin Rojas, Ari J Rosenberg, Minh Phan, Trisha Kaufmann, Christopher Plescia, Xiaoping Qing, Corinne Iacobucci, Ilian Tchakov, Kia Katchar, Klaus Orlinger, Katia Schlienger, David G Pfister","doi":"10.1136/jitc-2023-sitc2023.0679","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":500964,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"17 3","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study\",\"authors\":\"Alan L Ho, Alexander T Pearson, Siqing Fu, Marshall R Posner, Douglas Adkins, Lisle Nabell, Jiaxin Niu, Debra L Richardson, Rom S Leidner, Ki Chung, Douglas Laux, Jorge Nieva, Stuart Wong, Katerin Rojas, Ari J Rosenberg, Minh Phan, Trisha Kaufmann, Christopher Plescia, Xiaoping Qing, Corinne Iacobucci, Ilian Tchakov, Kia Katchar, Klaus Orlinger, Katia Schlienger, David G Pfister\",\"doi\":\"10.1136/jitc-2023-sitc2023.0679\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":500964,\"journal\":{\"name\":\"Regular and Young Investigator Award Abstracts\",\"volume\":\"17 3\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regular and Young Investigator Award Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jitc-2023-sitc2023.0679\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regular and Young Investigator Award Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jitc-2023-sitc2023.0679","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study